drug
darunavir
Marketedupdated 5mo agoby Janssen Therapeutics
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(0)
nothing on the calendar yet
Trials studying darunavir
- phase3Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
- —Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- phase4A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants
- phase1Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants
- phase1A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents
- phase1A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions
- phase1A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants
- phase1A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 26, 2026
86 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (14)
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Jun 26, 2027patentUS 7700645*PED268d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
- Dec 26, 2026compositionUS 770064586d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that